Development of a stable single-vial liposomal formulation for vincristine
Wenxue Mao,1 Fan Wu,2 Robert J Lee,3 Weigen Lu,4 Jianxin Wang11Department of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People’s Republic of China; 2College of Medicine, Des Moines University,...
Guardado en:
Autores principales: | Mao W, Wu F, Lee RJ, Lu W, Wang J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8564c3cf87b842dda4c94f2786156426 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang J, et al.
Publicado: (2016) -
Sub-Chronic Administration of Vincristine Sulfate Induces Renal Damage and Apoptosis in Rats via Induction of Oxidative Stress and Activation of Raf1-MEK1/2-Erk1/2 Signal Transduction
por: Shati,Ali A
Publicado: (2019) -
Isolation of Breast Cancer Stem Cell from MDA-MB231 Cell Line Using Vincristine
por: Ghanbari,Tara, et al.
Publicado: (2016) -
Brain Metastasis In A Case Of Canine Transmissible Venereal Tumor After A Supposed Successful Treatment With Vincristine Sulfate
por: Pedro PINCZOWSKI, et al.
Publicado: (2015) -
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
por: Zhang J, et al.
Publicado: (2018)